KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Equity (2016 - 2025)

Historic Return on Equity for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to 0.03%.

  • Pacira BioSciences' Return on Equity rose 1400.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.12% for FY2024, which is 1700.0% down from last year.
  • Per Pacira BioSciences' latest filing, its Return on Equity stood at 0.03% for Q3 2025, which was up 1400.0% from 0.16% recorded in Q2 2025.
  • Pacira BioSciences' 5-year Return on Equity high stood at 0.26% for Q2 2021, and its period low was 0.16% during Q2 2025.
  • In the last 5 years, Pacira BioSciences' Return on Equity had a median value of 0.03% in 2025 and averaged 0.03%.
  • Per our database at Business Quant, Pacira BioSciences' Return on Equity skyrocketed by 2900bps in 2021 and then crashed by -2400bps in 2025.
  • Quarter analysis of 5 years shows Pacira BioSciences' Return on Equity stood at 0.06% in 2021, then tumbled by -64bps to 0.02% in 2022, then soared by 139bps to 0.05% in 2023, then plummeted by -364bps to 0.13% in 2024, then soared by 122bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q3 2025, 0.16% for Q2 2025, and 0.13% during Q1 2025.